Table 3: Plasma saturated and monounsaturated fatty acids profile and estimated enzymatic activities indices in BD patients and controls.
| -
|
Controls (n=99) |
BD Patients (n=101) |
| -
|
% |
µg/ml |
% |
µg/ml |
| MA (C14:0) |
0.63 (0.50-0.84) |
26.28 (17.87-40.28) |
0.75 (0.55-0.98)* |
27.96 (19.46-42.49)* |
| PAM (C16:0) |
21.87 (20.25-23.26) |
856.17 (622.15-1082.05) |
22.31 (20.87-24.88)* |
881.54 (664.0-106.69)* |
| STA (C18:0) |
6.09 (5.26-6.70) |
237.45 (182.05-304.20) |
6.04 (5.31-7.59) |
233.11 (174.75-311.84) |
| Total SFA |
28.49 (26.67-30.98) |
1070.70 (891.52-1376.28) |
29.65 (27.24-32.43)* |
1156.77 (818.69-1408.79)* |
| POA (C16:1n-7) |
2.94 (2.01-4.26) |
107.27 (72.56-168.15) |
3.88 (2.72-5. 51)** |
130.13 (89.08-188.76)* |
| OLA (C18:1n-9) |
21.5 (19.79-23.66) |
639.81 (465.18-892.30) |
20.7 (18.78-23.28) |
584.72 (429.67-827.62) |
| Total MUFA |
24.73 (22.88-27.09) |
707.27 (543.81-976.93) |
25.25 (22.52-28.4) |
741.23 (536.35-1064.83) |
| Elongase |
0.28 (0.24-0.31) |
0.28 (0.25-0.31) |
0.27 (0.23-0.32) |
0.27 (0.23-0.32) |
| SCD-16 |
0.13 (0.09-0.19) |
0.12 (0.09-0.178) |
0.17 (0.12-0.24)** |
0.15 (0.11-0.21)* |
| SCD-18 |
3.55 (2.91-4.49) |
2.73 (2.27-3.46) |
3.30 (2.53-4.37) |
2.53 (1.98-3.40) |
BD: Behcet Disease; MA: Mystiric. PAM: Palmitic acid; STA: Stearic acid; POA: Palmitoleic acid; OLA: Oleic acid; SFA: Saturated fatty acids; MUFA: Monounsaturated fatty acids; SCD: Stearoyl CoA desaturase; %: percentage; µg:microgram ; ml: milliliter;µmol: micromole; *: p ≤ 0,05; **: p ≤ 0,001.